With the analysis among 292 patents, we discovered top 51 key players by total patent application. Endocyte, Inc., Eli Lilly & Co., Diasorin Italia SpA are dominant in this area. They take 79.45% of the total patent filing.
Indiana, United States
Patent: 151
Indiana, United States
Patent: 21
Illinois, United States
Patent: 7
California, United States
Patent: 6
Hunan Sheng, China
Patent: 4
Illinois, United States
Patent: 3
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
With the analysis among related 55 patents applied in the last 5 years. We discover 30 most active companies in this area. The fast-growing Endocyte, Inc., Io Therapeutics, Inc., Epicyt Pharma AB take 36.36% of patent filing during this period.
Indiana, United States
Patent: 8
California, United States
Patent: 6
Indiana, United States
Patent: 6
Hunan Sheng, China
Patent: 4
Zhejiang Sheng, China
Patent: 3
Massachusetts, United States
Patent: 2
Sichuan Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
With the analysis among related 55 patents in last 5 years, we discover 23 new entrants. Epicyt Pharma AB, Io Therapeutics, Inc., Changsha Golden Mile Medical Laboratory Co., Ltd. are the most active new entrants in this area.
California, United States
Patent: 6
Hunan Sheng, China
Patent: 4
Massachusetts, United States
Patent: 2
Massachusetts, United States
Patent: 1
Sichuan Sheng, China
Patent: 1
Beijing Shi, China
Patent: 1
Zhejiang Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
With the analysis among 57 patents, we discovered top 21 universities and scientific research institutions by total patent application. The Salk Institute for Biological Studies, Toyama Prefectural University, University of Tokyo are dominant in this area. They take 42.11% of the total patent filing.
California, United States
Patent: 6
Zhejiang Sheng, China
Patent: 5
Illinois, United States
Patent: 2
Texas, United States
Patent: 2
New South Wales, Australia
Patent: 2